You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cell cycle regulatory protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Interleukins in Periodontal Disease Progression

Recruiting
  • Periodontitis
  • Gingivitis
  • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
  • Assiut, Asyut, Egypt
    Department of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022

Contraceptives, Oral, Sex Hormone Trial in Toronto (Protein tracer drink)

Recruiting
  • Contraceptives, Oral
  • Sex Hormone
  • Protein tracer drink
  • Toronto, Ontario, Canada
    Goldring Centre for High Performance Sport at the University of
Nov 8, 2023

Serum Insulin-like Growth Factor Binding Protein-3 asPotential

Not yet recruiting
  • Colorectal Cancer
  • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
  • (no location specified)
May 6, 2023

Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • +2 more
  • Biopsy
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Aug 7, 2023

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Thoracic Sarcomas, Thorasic Cancers, Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Trial run by the NCI

Terminated
Has Results
  • Thoracic Sarcomas
  • +4 more
  • H1299 cell lysates
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 27, 2021

Th1, Th2, Th17 Phenotype in Urea Cycle Disorders

Active, not recruiting
  • Urea Cycle Disorder
  • Lysinuric Protein Intolerance
    • Istanbul, Turkey
      Istanbul University-Cerrahpasa
    Jan 23, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Scottsdale (Paricalcitol (Zemplar))

    Active, not recruiting
    • Pancreatic Cancer
    • +4 more
    • Paricalcitol (Zemplar)
    • Scottsdale, Arizona
      HonorHealth Research Institute
    Feb 16, 2022

    Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Squamous Carcinoma
    • +7 more
    • Los Angeles, California
    • +9 more
    Dec 17, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Greenwich, Connecticut
    • +27 more
    Dec 30, 2022

    Head Neck Cancer Trial in United States (fruit and vegetable extracts, )

    Completed
    Has Results
    • Head and Neck Cancer
    • fruit and vegetable extracts
    • placebo
    • Santa Rosa, California
    • +27 more
    Sep 7, 2021

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

    Recruiting
    • Diffuse Intrinsic Pontine Glioma
    • Diffuse Midline Glioma, H3 K27M-Mutant
    • rHSC-DIPGVax
    • +2 more
    • Orange, California
    • +2 more
    Nov 10, 2022

    Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

    Not yet recruiting
    • Sickle Cell Disease, Beta Thalassemia Intermedia
    • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
    • (no location specified)
    May 30, 2023

    Hematologic Malignancy Trial in Tianjin (IMM01)

    Terminated
    • Hematologic Malignancy
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Sciences and Peking Union Medical Col
    May 5, 2023

    Advanced MTAP-null Solid Tumors Trial in Worldwide (AMG 193, Docetaxel)

    Recruiting
    • Advanced MTAP-null Solid Tumors
    • Duarte, California
    • +17 more
    Aug 11, 2022

    Kaposi Sarcoma Trial run by the NCI (Abemaciclib)

    Recruiting
    • Kaposi Sarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

    Terminated
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • +2 more
    • ImmunoPulse
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Sep 1, 2022

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

    Enrolling by invitation
    • Hepatocellular Carcinoma Non-resectable
    • +3 more
    • lenvatinib + sindilimab/carrelizumab
    • TACE
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    May 23, 2022

    Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

    Withdrawn
    • Amyloidosis
    • Light Chain (AL) Amyloidosis
    • (no location specified)
    Dec 29, 2022

    Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney

    Recruiting
    • Acute Kidney Injury
    • Nephrocheck (AKI score)
    • Milan, Italy
      Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico
    Jun 19, 2023

    Cancer Trial in Genova (Short-term modified fasting)

    Recruiting
    • Cancer
    • Short-term modified fasting
    • Genova, Italy
      San Martino Hospital
    Feb 17, 2023